Thought Leadership
Email Page
How 2 Recent Court Cases Could Impact Follow-On Biologics Strategy
July 23, 2019
Stacie Ropka, Drew Hillier, and Aaron Savit
Biosimilar Development

Axinn partner Stacie Ropka, associate Drew Hillier, and summer associate Aaron Savit authored the Biosimilar Development article, "How 2 Recent Court Cases Could Impact Follow-On Biologics Strategy."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.